ARQT(Arcutis Biotherapeutics, Inc.) · 财务报表

ARQT(Arcutis Biotherapeutics, Inc.) 的财务报表:医疗保健,生物技术。数据来自 SEC 公开申报与市场行情,不构成投资建议。

近年年度财务(SEC XBRL)
科目FY 截至 2021-12-31FY 截至 2022-12-31FY 截至 2023-12-31FY 截至 2024-12-31FY 截至 2025-12-31
营业收入$0$3.69M$59.61M$196.54M$376.07M
毛利润$0$2.93M$54.62M$177.41M$339.38M
营业利润−$206.53M−$301.63M−$241.10M−$128.40M−$12.23M
净利润−$206.36M−$311.46M−$262.14M−$140.04M−$16.14M
经营现金流−$174.63M−$257.71M−$247.06M−$112.16M−$5.62M
自由现金流−$175.62M−$258.05M−$247.49M−$112.30M−$6.31M
摊薄每股收益$-4.18$-5.66$-3.78$-1.16$-0.13

Arcutis Biotherapeutics, Inc. ARQT